文献速递垂体与肾上腺疾病

住院垂体功能减退患者死亡率过高——一项基于人群的配对队列研究

Excess Mortality Among Hospitalized Patients With Hypopituitarism-A Population-Based, Matched-Cohort Study.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

这项基于人群的配对队列研究纳入2012至2017年住院成人垂体功能减退患者,按1:1倾向评分匹配普通内科住院患者,共6764例。垂体功能减退患者院内死亡风险升高(OR 1.32),主要见于合并尿崩症者(OR 3.69),且ICU入住率、30天和1年再入院率更高、住院时间延长2.4天。

要点

  • 住院垂体功能减退患者院内死亡风险高于匹配对照(OR 1.32)。
  • 合并尿崩症患者院内死亡风险明显升高(OR 3.69)。
  • 垂体功能减退患者ICU入住率更高、住院时间延长2.4天、再入院率更高。

核心结论

  • 垂体功能减退患者因急性内科疾病住院时死亡风险及不良临床结局风险升高,合并尿崩症者最为明显。

研究设计与样本

  • 基于人群的配对队列研究,2012至2017年,住院成人垂体功能减退患者按1:1倾向评分与普通内科住院队列匹配,匹配后共纳入6764例。

主要发现

  • 垂体功能减退患者院内全因死亡198例(5.9%),匹配对照164例(4.9%),OR 1.32(95%CI 1.06-1.65),P=.013。
  • 死亡风险升高主要见于合并尿崩症患者,OR 3.69(95%CI 2.44-5.58),P<.001。
  • 垂体功能减退患者ICU入住率高于匹配对照,OR 1.50(95%CI 1.30-1.74),P<.001。
  • 垂体功能减退患者住院时间较匹配对照延长2.4天(95%CI 1.94-2.95),P<.001。
  • 垂体功能减退患者30天再入院OR 1.31(95%CI 1.13-1.51),P<.001;1年再入院OR 1.29(95%CI 1.17-1.42),P<.001。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Patients with hypopituitarism face excess mortality in the long-term outpatient setting. However, associations of pituitary dysfunction with outcomes in acutely hospitalized patients are lacking. OBJECTIVE: The objective of this work is to assess clinical outcomes of hospitalized patients with hypopituitarism with or without diabetes insipidus (DI). DESIGN, SETTING, AND PATIENTS: In this population-based, matched-cohort study from 2012 to 2017, hospitalized adult patients with a history of hypopituitarism were 1:1 propensity score-matched with a general medical inpatient cohort. MAIN OUTCOME MEASURES: The primary outcome was in-hospital mortality. Secondary outcomes included all-cause readmission rates within 30 days and 1 year, intensive care unit (ICU) admission rates, and length of hospital stay. RESULTS: After matching, 6764 cases were included in the study. In total, 3382 patients had hypopituitarism and of those 807 (24%) suffered from DI. All-cause in-hospital mortality occurred in 198 (5.9%) of patients with hypopituitarism and in 164 (4.9%) of matched controls (odds ratio [OR] 1.32, [95% CI, 1.06-1.65], P = .013). Increased mortality was primarily observed in patients with DI (OR 3.69 [95% CI, 2.44-5.58], P < .001). Patients with hypopituitarism had higher ICU admissions (OR 1.50 [95% CI, 1.30-1.74], P < .001), and faced a 2.4-day prolonged length of hospitalization (95% CI, 1.94-2.95, P < .001) compared to matched controls. Risk of 30-day (OR 1.31 [95% CI, 1.13-1.51], P < .001) and 1-year readmission (OR 1.29 [95% CI, 1.17-1.42], P < .001) was higher among patients with hypopituitarism as compared with medical controls. CONCLUSIONS: Patients with hypopituitarism are highly vulnerable once hospitalized for acute medical conditions with increased risk of mortality and adverse clinical outcomes. This was most pronounced among those with DI.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Ebrahimi F, Kutz A, Wagner U, et al. Excess Mortality Among Hospitalized Patients With Hypopituitarism-A Population-Based, Matched-Cohort Study. J Clin Endocrinol Metab. 2020. PMID: 32785679. doi:10.1210/clinem/dgaa517

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。